Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era

BACKGROUND: The incidence of hepatocellular carcinoma (HCC) is increasing. Development of newer therapeutic modalities has changed the paradigm of HCC treatment in recent years. So, the aim of our study is to analyze the impact of these treatment modalities into the survival of HCC patients, based o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gastrointest Oncol
Autori principali: Shah, Chintan, Mramba, Lazarus K., Bishnoi, Rohit, Bejjanki, Harini, Chhatrala, Hardik Satish, Chandana, Sreenivasa R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5674257/
https://ncbi.nlm.nih.gov/pubmed/29184682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.06.16
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi